Chemoinformaics analysis of 2-METHYLBUTYRONITRILE
| Molecular Weight | 83.134 | nRot | 1 |
| Heavy Atom Molecular Weight | 74.062 | nRig | 1 |
| Exact Molecular Weight | 83.0735 | nRing | 0 |
| Solubility: LogS | -0.921 | nHRing | 0 |
| Solubility: LogP | 1.053 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 15 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 6 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 9 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 5 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 15.4511 |
| nHD | 0 | BPOL | 9.59886 |
| QED | 0.472 |
| Synth | 3.307 |
| Natural Product Likeliness | -1.343 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.002 |
| HIA | 0.004 |
| CACO-2 | -4.384 |
| MDCK | 0.0000488 |
| BBB | 0.997 |
| PPB | 0.255245 |
| VDSS | 1.007 |
| FU | 0.747016 |
| CYP1A2-inh | 0.785 |
| CYP1A2-sub | 0.779 |
| CYP2c19-inh | 0.053 |
| CYP2c19-sub | 0.313 |
| CYP2c9-inh | 0.028 |
| CYP2c9-sub | 0.467 |
| CYP2d6-inh | 0.012 |
| CYP2d6-sub | 0.153 |
| CYP3a4-inh | 0.016 |
| CYP3a4-sub | 0.282 |
| CL | 9.887 |
| T12 | 0.835 |
| hERG | 0.011 |
| Ames | 0.241 |
| ROA | 0.966 |
| SkinSen | 0.447 |
| Carcinogencity | 0.586 |
| EI | 0.991 |
| Respiratory | 0.977 |
| NR-Aromatase | 0.003 |
| Antiviral | No |
| Prediction | 0.944861 |